Following our 2024 Neuroscience Recap, we highlight several key events to anticipate this year. We have included major clinical events as well as thoughts on the biopharmaceutical industry’s response to the new administration’s impact on the neuroscience market.
Lumanity offers extensive experience-based strategic guidance and insights in the field of neuroscience. Our goal is to provide our clients with actionable solutions that de-risk and optimize the development and commercialization of therapies, ultimately improving the lives of patients who are impacted across a range of conditions.
